Carbamate substituted 2-amino-4,6-diphenylpyrimidines as adenosine receptor antagonists
Date
2016Author
Robinson, Sarel J.
Petzer, Jacobus P.
Terre'Blanche, Gisella
Petzer, Anél
Lourens, Anna C.U.
Rousseau, Amanda L.
Metadata
Show full item recordAbstract
A novel series of carbamate substituted 2-amino-4,6-diphenylpyrimidines was evaluated as potential dual adenosine A1 and A2A receptor antagonists. The majority of the synthesised compounds exhibited promising dual affinities, with A1Ki values ranging from 0.175 to 10.7 nM and A2AKi values ranging from 1.58 to 451 nM. The in vivo activity illustrated for 3-(2-amino-6-phenylpyrimidin-4-yl)phenyl morpholine-4-carboxylate (4c) is indicative of the potential of these compounds as therapeutic agents in the treatment of Parkinson’s disease, although physicochemical properties may require optimisation
URI
http://hdl.handle.net/10394/23160https://www.sciencedirect.com/science/article/pii/S0960894X1630004X
https://doi.org/10.1016/j.bmcl.2016.01.004
Collections
- Faculty of Health Sciences [2404]